150 related articles for article (PubMed ID: 19688969)
1. Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma.
Won KY; Park HR; Park YK
Tumori; 2009; 95(3):311-6. PubMed ID: 19688969
[TBL] [Abstract][Full Text] [Related]
2. Regulators of skeletal development: a cluster analysis of 206 bone tumors reveals diagnostically useful markers.
Horvai AE; Roy R; Borys D; O'Donnell RJ
Mod Pathol; 2012 Nov; 25(11):1452-61. PubMed ID: 22766796
[TBL] [Abstract][Full Text] [Related]
3. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
4. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
5. p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases.
Righi A; Gambarotti M; Sbaraglia M; Sisto A; Ferrari S; Dei Tos AP; Picci P
Hum Pathol; 2016 Dec; 58():15-23. PubMed ID: 27544803
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression in human osteosarcoma is a marker for survival.
Trieb K; Lehner R; Stulnig T; Sulzbacher I; Shroyer KR
Eur J Surg Oncol; 2003 May; 29(4):379-82. PubMed ID: 12711293
[TBL] [Abstract][Full Text] [Related]
7. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
Li Z; Jia M; Wu X; Cui J; Pan A; Li L
Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
[TBL] [Abstract][Full Text] [Related]
9. XB130 expression in human osteosarcoma: a clinical and experimental study.
Wang X; Wang R; Liu Z; Hao F; Huang H; Guo W
Int J Clin Exp Pathol; 2015; 8(3):2565-73. PubMed ID: 26045762
[TBL] [Abstract][Full Text] [Related]
10. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M
Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692
[TBL] [Abstract][Full Text] [Related]
11. Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.
Yang J; Zhao L; Tian W; Liao Z; Zheng H; Wang G; Chen K
BMC Med Genomics; 2013 Dec; 6():56. PubMed ID: 24330824
[TBL] [Abstract][Full Text] [Related]
12. The cancer-related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma.
Liang S; Li Y; Wang B
Int J Clin Oncol; 2021 Dec; 26(12):2347-2354. PubMed ID: 34546483
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients' prognosis.
Zhu H; Tang J; Tang M; Cai H
Diagn Pathol; 2013 Nov; 8():183. PubMed ID: 24188461
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.
Sadikovic B; Thorner P; Chilton-Macneill S; Martin JW; Cervigne NK; Squire J; Zielenska M
BMC Cancer; 2010 May; 10():202. PubMed ID: 20465837
[TBL] [Abstract][Full Text] [Related]
15. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
16. P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.
Bu J; Li H; Liu LH; Ouyang YR; Guo HB; Li XY; Xiao T
Int J Clin Exp Pathol; 2014; 7(9):6091-6. PubMed ID: 25337256
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic values of fibronectin and integrin αvβ3 expression in primary osteosarcoma.
Shi K; Wang SL; Shen B; Yu FQ; Weng DF; Lin JH
World J Surg Oncol; 2019 Jan; 17(1):23. PubMed ID: 30691475
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of bax, cytochrome C, and caspase-8 protein expression in primary osteosarcoma.
Kaseta MK; Gomatos IP; Khaldi L; Tzagarakis GP; Alevizos L; Themistocleous GS; Leandros E; Soucacos PN
Hybridoma (Larchmt); 2007 Dec; 26(6):355-62. PubMed ID: 18158779
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]